Filing Details

Accession Number:
0001127602-19-035863
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-26 17:36:54
Reporting Period:
2019-12-24
Accepted Time:
2019-12-26 17:36:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341125 Richard Kuntz 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Svp & Chief Medical & Science No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-12-24 5,067 $113.64 74,032 No 4 S Direct
Ordinary Shares Disposition 2019-12-24 3,019 $113.63 71,013 No 4 S Direct
Ordinary Shares Acquisiton 2019-12-24 2,404 $41.60 73,417 No 4 M Direct
Ordinary Shares Disposition 2019-12-24 2,404 $113.60 71,013 No 4 S Direct
Ordinary Shares Acquisiton 2019-12-24 1,808 $55.32 72,821 No 4 M Direct
Ordinary Shares Disposition 2019-12-24 1,808 $113.66 71,013 No 4 S Direct
Ordinary Shares Acquisiton 2019-12-24 38,558 $55.32 109,571 No 4 M Direct
Ordinary Shares Disposition 2019-12-24 38,558 $113.56 71,013 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-12-24 2,404 $0.00 2,404 $41.60
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-12-24 1,808 $0.00 1,808 $55.32
Ordinary Shares Stock Option (Right to Buy) Disposition 2019-12-24 38,558 $0.00 38,558 $55.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-10-29 No 4 M Direct
0 2023-07-29 No 4 M Direct
0 2023-07-29 No 4 M Direct
Footnotes
  1. This balance increased by 283 shares due to exempt transactions such as dividend reinvestment.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $113.48 to $113.66, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
  3. This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  4. This option to purchase 1,808 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  5. This option to purchase 38,558 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 38,558 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.